SCHEMBL26552001

SCHEMBL26552001

Cc1ccc(-c2ccc(-c3ccc4cc(-c5ccccc5)ccc4c3)cn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CTRC Q99895 1/20 0.48
AGTR1 P30556 1/20 0.46
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SLC2A1 P11166 1/20 0.45
ALDH1A3 P47895 1/20 0.45
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 3/20 0.44
FLT3 P36888 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2187794 0.90 MEN1 (0.50) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL12339169 0.90 MEN1 (0.50) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL26567152 0.89 CTRC (0.50) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL25135470 0.86 CYP11B1 (0.58) MEN1KMT2AKDM4EALDH1A1HSD17B1
SCHEMBL26551994 0.86 PDGFRB (0.40) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL26565579 0.86 PDGFRB (0.40) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL18325218 0.85 L3MBTL1 (0.48) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL26564732 0.85 CYP11B1 (0.56) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL26564869 0.84 CYP11B1 (0.51) HSD17B1HSD17B2NPC1RAB9ACYP11B1
SCHEMBL18325357 0.83 CTRC (0.49) MEN1KMT2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 MEN1 1661/4885KMT2A 2471/4885KDM4E 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.